Journal article
Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?
- Abstract:
-
Alemtuzumab (Campath-1H) has been widely used for T-cell depletion following both conventional and reduced-intensity conditioning allografts. We studied the impact of alemtuzumab used in vivo and in vitro on infections, immune reconstitution, and allograft outcome. The use of alemtuzumab in vivo following reduced-intensity conditioning and unrelated donor conventional transplantation was associated with durable engraftment and significant reduction in graft-versus-host disease (GVHD) but at t...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Transplantation proceedings
- Volume:
- 36
- Issue:
- 5
- Pages:
- 1225-1227
- Publication date:
- 2004-06-01
- DOI:
- EISSN:
-
1873-2623
- ISSN:
-
0041-1345
- Source identifiers:
-
9804
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:9804
- UUID:
-
uuid:d2c17132-aef2-4c9b-b2d5-dbf51fdc5344
- Local pid:
- pubs:9804
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2004
If you are the owner of this record, you can report an update to it here: Report update to this record